Developer docs
API playgroundTry for free, no card

Search company profiles

Hc2 Holdings Inc

Full company profile

uuid02lxtgd

Namestring
Hc2 Holdings Inc
Legal namestring
Innovate Corp
Websiteurl
hc2.com
Company typeenum
Public
Founded yearint
1994
Descriptiontext

Innovate Corp (formerly HC2 Holdings Inc.) is a NYSE-listed diversified holding company (ticker: VATE) headquartered in New York that operates across three segments — Infrastructure, Life Sciences, and Spectrum — through wholly-owned portfolio subsidiaries. The Infrastructure segment is anchored by DBM Global, a leading structural steel and industrial construction company serving enterprise clients through project-based contracts. The Life Sciences segment comprises Pansend Life Sciences (the parent for healthcare innovation), R2 Technologies (holder of an FDA-cleared device for aesthetic dermatology that addresses visible signs of skin aging), and MediBeacon (developer of an FDA-approved, first-in-kind Transdermal GFR System for point-of-care kidney function assessment, targeting a stated $7B market with no direct equivalent product). The Spectrum segment is HC2 Broadcasting, one of the largest U.S. broadcast station groups, operating 257 stations across 112 markets and owning 2.7 billion MHz POPs of spectrum.

The company's revenue mechanics are diversified across industrial construction project contracts, broadcasting station operations, and emerging healthcare product commercialization (post-FDA milestones). GTM varies by subsidiary: DBM Global uses direct enterprise project-based sales; healthcare subsidiaries (R2 Technologies, MediBeacon) distribute FDA-cleared/approved medical devices through healthcare providers and aesthetic dermatology channels; HC2 Broadcasting operates broadcast television stations. Pricing information is not publicly disclosed. The company has executed portfolio reallocation in 2026, including a successful broadcasting refinancing and agreed partial sale of broadcasting assets, alongside a cash dividend from DBM Global — signaling ongoing strategic restructuring of the asset base.

Leadership comprises Avie Glazer as Chairman of the Board, Paul Voigt as Interim Chief Executive Officer, and Michael Sena as Chief Financial Officer. The Interim CEO posture coincides with the broadcasting divestiture and broader portfolio reshaping. Investor relations are handled at ir@innovatecorp.com.

Short descriptiontext

Innovate Corp (NYSE: VATE), formerly HC2 Holdings Inc., is a New York-based diversified holding company operating infrastructure (DBM Global structural steel construction), life sciences (Pansend, R2 Technologies, MediBeacon FDA-approved kidney diagnostics), and spectrum (HC2 Broadcasting, 257 stations, 2.7B MHz POPs) segments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
diversified holding company, structural steel construction, broadcast television stations, medical device manufacturing, spectrum broadcasting
Industry1 code
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Diversified Holding Company
Social media profiles1 record
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1DBM Global
Description

Leading structural steel and industrial construction company

innovatecorp.com
+4 more records
Core offering1 text field

Innovate Corp is a diversified holding company that operates through wholly-owned subsidiaries across three segments: Infrastructure (DBM Global - structural steel and industrial construction), Life Sciences (Pansend Life Sciences, R2 Technologies - FDA-cleared aesthetic dermatology device, and MediBeacon - FDA-approved Transdermal GFR kidney function assessment system), and Spectrum (HC2 Broadcasting - one of the largest U.S. broadcast station groups with 257 stations in 112 markets).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 257 broadcast stations operating across 112 U.S. markets
Product overview1 text field

Innovate Corp is a diversified holding company with strategic portfolio segments spanning infrastructure, life sciences, and spectrum broadcasting. The infrastructure division includes DBM Global, a structural steel and industrial construction company. The life sciences segment encompasses Pansend Life Sciences focused on healthcare innovation, R2 Technologies with its FDA-cleared aesthetic dermatology device, and MediBeacon's FDA-approved kidney function assessment system (TGFR). The spectrum division features HC2 Broadcasting, one of the largest U.S. broadcast station groups operating 257 stations across 112 markets with 2.7 billion MHz POPs of spectrum.

Product and service5 records
1DBM Global
CategoryIndustrial Construction Services
Description

DBM Global is a leading structural steel and industrial construction company serving as the infrastructure segment of Innovate Corp's portfolio, providing large-scale structural steel fabrication and erection services to industrial construction clients through project-based contracts.

2Pansend Life Sciences
CategoryHealthcare Technology
Description

Pansend Life Sciences develops innovative healthcare technologies to address unmet medical needs within the life sciences segment of Innovate Corp's portfolio.

3R2 Technologies Skin Treatment Device
CategoryMedical Devices
Description

R2 Technologies has FDA clearance for a revolutionary device that soothes, brightens the skin and effectively treats visible signs of skin aging caused by inflammation, targeting the fast-growing global aesthetic dermatology market.

4MediBeacon Transdermal GFR System (TGFR)
CategoryMedical Devices
Description

MediBeacon's Transdermal GFR System (TGFR) is a first-in-kind FDA-approved point of care product for assessment of kidney function in patients with normal or impaired renal function, addressing a $7B market with no equivalent product currently available.

5HC2 Broadcasting
CategoryBroadcast Television
Description

HC2 Broadcasting is one of the largest broadcast station groups in the United States, operating 257 stations across 112 markets and owning 2.7 billion MHz POPs of spectrum.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

A larger medical technology company focused on women's health diagnostics and surgical devices. Comparable to MediBeacon/R2 on FDA-regulated medical device commercialization and specialty-diagnostics business model, though at much larger scale and broader product portfolio.

TypeDirect peer
Description

Designs, develops, and markets aesthetic medical devices used by physicians in dermatology and plastic surgery practices. Directly comparable to R2 Technologies' FDA-cleared aesthetic dermatology platform targeting the same clinician channel.

TypeBroad incumbent
Description

A U.S. diversified holding company with operating subsidiaries in insurance, energy, and hospitality. Comparable to Innovate Corp as a publicly traded diversified holdco where capital allocation across unrelated operating businesses drives value.

TypeDirect peer
Description

Develops and commercializes energy-based aesthetic systems for dermatologists and aesthetic practitioners. Comparable to R2 Technologies in product category, regulatory pathway, and go-to-customer profile.

TypeBroad incumbent
Description

A diversified holding company with operating businesses across multiple industries under a controlled-company structure. Comparable to Innovate Corp's diversified holdco model with controlling-shareholder governance and capital-allocation-driven strategy.

TypeDirect peer
Description

Operates a large portfolio of U.S. television broadcast stations with portfolio monetization, including spectrum-related transactions. Comparable to HC2 Broadcasting on station-group economics and spectrum-repricing optionality.

TypeDirect peer
Description

A diversified broadcast and digital media company operating local TV stations across U.S. markets. Comparable to HC2 Broadcasting in station footprint, advertising-driven revenue model, and exposure to retransmission fees.

TypeDirect peer
Description

The largest U.S. television broadcast station group, operating stations across hundreds of markets. Closely comparable to HC2 Broadcasting on operating model, retransmission economics, and spectrum asset profile.

TypeDirect peer
Description

One of the largest U.S. television broadcast station operators, owning and operating stations across many markets with significant spectrum holdings. Directly comparable to HC2 Broadcasting in scale, regulatory model, and exposure to broadcast TV economics and spectrum value.

TypeDirect peer
Description

Operates engineered composites-focused industrial segments serving aerospace and industrial end markets through engineered process and structural solutions. Comparable to DBM Global's structural steel and industrial construction focus with project-driven, engineering-intensive delivery.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hc2 Holdings Inc

Diversified Holding Companyhc2.com

Innovate Corp (NYSE: VATE), formerly HC2 Holdings Inc., is a New York-based diversified holding company operating infrastructure (DBM Global structural steel construction), life sciences (Pansend, R2 Technologies, MediBeacon FDA-approved kidney diagnostics), and spectrum (HC2 Broadcasting, 257 stations, 2.7B MHz POPs) segments.

What Hc2 Holdings Inc does

Innovate Corp (formerly HC2 Holdings Inc.) is a NYSE-listed diversified holding company (ticker: VATE) headquartered in New York that operates across three segments — Infrastructure, Life Sciences, and Spectrum — through wholly-owned portfolio subsidiaries. The Infrastructure segment is anchored by DBM Global, a leading structural steel and industrial construction company serving enterprise clients through project-based contracts. The Life Sciences segment comprises Pansend Life Sciences (the parent for healthcare innovation), R2 Technologies (holder of an FDA-cleared device for aesthetic dermatology that addresses visible signs of skin aging), and MediBeacon (developer of an FDA-approved, first-in-kind Transdermal GFR System for point-of-care kidney function assessment, targeting a stated $7B market with no direct equivalent product). The Spectrum segment is HC2 Broadcasting, one of the largest U.S. broadcast station groups, operating 257 stations across 112 markets and owning 2.7 billion MHz POPs of spectrum.

The company's revenue mechanics are diversified across industrial construction project contracts, broadcasting station operations, and emerging healthcare product commercialization (post-FDA milestones). GTM varies by subsidiary: DBM Global uses direct enterprise project-based sales; healthcare subsidiaries (R2 Technologies, MediBeacon) distribute FDA-cleared/approved medical devices through healthcare providers and aesthetic dermatology channels; HC2 Broadcasting operates broadcast television stations. Pricing information is not publicly disclosed. The company has executed portfolio reallocation in 2026, including a successful broadcasting refinancing and agreed partial sale of broadcasting assets, alongside a cash dividend from DBM Global — signaling ongoing strategic restructuring of the asset base.

Leadership comprises Avie Glazer as Chairman of the Board, Paul Voigt as Interim Chief Executive Officer, and Michael Sena as Chief Financial Officer. The Interim CEO posture coincides with the broadcasting divestiture and broader portfolio reshaping. Investor relations are handled at ir@innovatecorp.com.

Hc2 Holdings Inc firmographics

Firmographics
Name
Hc2 Holdings Inc
Legal name
Innovate Corp
Website
https://hc2.com
Company type
Public
Founded year
1994
Operating status
Operating
Headcount range
11–50 employees
Short description
Innovate Corp (NYSE: VATE), formerly HC2 Holdings Inc., is a New York-based diversified holding company operating infrastructure (DBM Global structural steel construction), life sciences (Pansend, R2 Technologies, MediBeacon FDA-approved kidney diagnostics), and spectrum (HC2 Broadcasting, 257 stations, 2.7B MHz POPs) segments.
Ownership category
akta.pro rank

Hc2 Holdings Inc industry classification

Industry
Product category
Diversified Holding Company
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Diversified holding company
  • Structural steel construction
  • Broadcast television stations
  • Medical device manufacturing
  • Spectrum broadcasting

Where Hc2 Holdings Inc is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

Hc2 Holdings Inc business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

Hc2 Holdings Inc product offering

Product offering

Core offering

Innovate Corp is a diversified holding company that operates through wholly-owned subsidiaries across three segments: Infrastructure (DBM Global - structural steel and industrial construction), Life Sciences (Pansend Life Sciences, R2 Technologies - FDA-cleared aesthetic dermatology device, and MediBeacon - FDA-approved Transdermal GFR kidney function assessment system), and Spectrum (HC2 Broadcasting - one of the largest U.S. broadcast station groups with 257 stations in 112 markets).

Product overview

Innovate Corp is a diversified holding company with strategic portfolio segments spanning infrastructure, life sciences, and spectrum broadcasting. The infrastructure division includes DBM Global, a structural steel and industrial construction company. The life sciences segment encompasses Pansend Life Sciences focused on healthcare innovation, R2 Technologies with its FDA-cleared aesthetic dermatology device, and MediBeacon's FDA-approved kidney function assessment system (TGFR). The spectrum division features HC2 Broadcasting, one of the largest U.S. broadcast station groups operating 257 stations across 112 markets with 2.7 billion MHz POPs of spectrum.

Differentiator

Problem solved

Functional benefit

Brands

  • DBM Global: Leading structural steel and industrial construction company
  • Pansend Life Sciences
  • R2 Technologies
  • MediBeacon
  • HC2 Broadcasting

Products and services

  • DBM Global DBM Global is a leading structural steel and industrial construction company serving as the infrastructure segment of Innovate Corp's portfolio, providing large-scale structural steel fabrication and erection services to industrial construction clients through project-based contracts.
  • Pansend Life Sciences Pansend Life Sciences develops innovative healthcare technologies to address unmet medical needs within the life sciences segment of Innovate Corp's portfolio.
  • R2 Technologies Skin Treatment Device R2 Technologies has FDA clearance for a revolutionary device that soothes, brightens the skin and effectively treats visible signs of skin aging caused by inflammation, targeting the fast-growing global aesthetic dermatology market.
  • MediBeacon Transdermal GFR System (TGFR) MediBeacon's Transdermal GFR System (TGFR) is a first-in-kind FDA-approved point of care product for assessment of kidney function in patients with normal or impaired renal function, addressing a $7B market with no equivalent product currently available.
  • HC2 Broadcasting HC2 Broadcasting is one of the largest broadcast station groups in the United States, operating 257 stations across 112 markets and owning 2.7 billion MHz POPs of spectrum.

Quantifiable outcome

  • 257 broadcast stations operating across 112 U.S. markets

Companies that use Hc2 Holdings Inc

Customer profile

Segments3 records

Ideal customer profiles3 records

Hc2 Holdings Inc technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Hc2 Holdings Inc partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Hc2 Holdings Inc competitors and assessment

Company assessment

Broad incumbents

  • Hologic, Inc. A larger medical technology company focused on women's health diagnostics and surgical devices. Comparable to MediBeacon/R2 on FDA-regulated medical device commercialization and specialty-diagnostics business model, though at much larger scale and broader product portfolio.
  • Loews Corporation: A U.S. diversified holding company with operating subsidiaries in insurance, energy, and hospitality. Comparable to Innovate Corp as a publicly traded diversified holdco where capital allocation across unrelated operating businesses drives value.
  • Icahn Enterprises L.P. A diversified holding company with operating businesses across multiple industries under a controlled-company structure. Comparable to Innovate Corp's diversified holdco model with controlling-shareholder governance and capital-allocation-driven strategy.

Direct peers

  • InMode Ltd. Designs, develops, and markets aesthetic medical devices used by physicians in dermatology and plastic surgery practices. Directly comparable to R2 Technologies' FDA-cleared aesthetic dermatology platform targeting the same clinician channel.
  • Cutera, Inc. Develops and commercializes energy-based aesthetic systems for dermatologists and aesthetic practitioners. Comparable to R2 Technologies in product category, regulatory pathway, and go-to-customer profile.
  • Gray Television, Inc. Operates a large portfolio of U.S. television broadcast stations with portfolio monetization, including spectrum-related transactions. Comparable to HC2 Broadcasting on station-group economics and spectrum-repricing optionality.
  • Tegna Inc. A diversified broadcast and digital media company operating local TV stations across U.S. markets. Comparable to HC2 Broadcasting in station footprint, advertising-driven revenue model, and exposure to retransmission fees.
  • Nexstar Media Group, Inc. The largest U.S. television broadcast station group, operating stations across hundreds of markets. Closely comparable to HC2 Broadcasting on operating model, retransmission economics, and spectrum asset profile.
  • Sinclair Broadcast Group, Inc. One of the largest U.S. television broadcast station operators, owning and operating stations across many markets with significant spectrum holdings. Directly comparable to HC2 Broadcasting in scale, regulatory model, and exposure to broadcast TV economics and spectrum value.
  • Albany International Corp. Operates engineered composites-focused industrial segments serving aerospace and industrial end markets through engineered process and structural solutions. Comparable to DBM Global's structural steel and industrial construction focus with project-driven, engineering-intensive delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Hc2 Holdings Inc social profiles

Digital presence

Hc2 Holdings Inc financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hc2 Holdings Inc leadership team

Management profile

Number of profiles

Profiles3 records

Hc2 Holdings Inc subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Hc2 Holdings Inc funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hc2 Holdings Inc M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hc2 Holdings Inc

What does Hc2 Holdings Inc do?

Innovate Corp is a diversified holding company that operates through wholly-owned subsidiaries across three segments: Infrastructure (DBM Global - structural steel and industrial construction), Life Sciences (Pansend Life Sciences, R2 Technologies - FDA-cleared aesthetic dermatology device, and MediBeacon - FDA-approved Transdermal GFR kidney function assessment system), and Spectrum (HC2 Broadcasting - one of the largest U.S. broadcast station groups with 257 stations in 112 markets).

Is Hc2 Holdings Inc a public or private company?

Hc2 Holdings Inc is a public company. It is classified as public and is currently operating.

When was Hc2 Holdings Inc founded?

Hc2 Holdings Inc was founded in 1994. It employs 11 to 50 people.

Where is Hc2 Holdings Inc based?

Hc2 Holdings Inc is headquartered in New York, United States, in the North America region.

Who are Hc2 Holdings Inc's main competitors?

Broad incumbents on record are Hologic, Inc., Loews Corporation and Icahn Enterprises L.P.. Direct peers are InMode Ltd., Cutera, Inc., Gray Television, Inc., Tegna Inc., Nexstar Media Group, Inc., Sinclair Broadcast Group, Inc. and Albany International Corp..

Does Hc2 Holdings Inc have an API?

No public API is recorded for Hc2 Holdings Inc.

What industry is Hc2 Holdings Inc in?

Hc2 Holdings Inc's product category is Diversified Holding Company. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 3345 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comINNOVATE Q2 2026 slides: Infrastructure drives 74% revenue surge By Investing.comINNOVATE Corp. reported a 74.2% year-over-year surge in Q2 2026 revenue to $421.6 million, driven by its Infrastructure segment DBM Global, and swung to a net profit of $10.7 million compared to a prior-year loss. The company also announced a definitive merger agreement whereby CONX Corp. is expected to acquire approximately 75% of its Spectrum broadcasting unit, HC2 Broadcasting. Following the earnings release and strategic update, INNOVATE's shares surged more than 40% in after-hours trading.GlobeNewswireINNOVATE Corp. Completes Name Change from HC2 Holdings, Inc.INNOVATE Corp. completed its name change from HC2 Holdings, Inc., effective September 20, 2021, with trading under the new ticker VATE. The company, a portfolio of assets in Infrastructure, Life Sciences, and Spectrum, will use a new CUSIP and ISIN, and no stockholder action is required.GlobeNewswireHC2 Holdings, Inc. Announces New Name, INNOVATE Corp.HC2 Holdings, Inc. announced it will change its name to INNOVATE Corp., effective by the end of Q3 2021. The company will rebrand and trade under a new symbol, with its portfolio focused on infrastructure, life sciences, and spectrum. The name change reflects its corporate ethos and stakeholder capitalism focus.YahooHC2 Holdings (HCHC) Unit Buys Banker Steel, Enters Credit AgreementHC2 Holdings acquired Lynchburg-based Banker Steel Holdco LLC through its infrastructure arm, DBM Global, in a $145 million transaction announced on March 15, 2021. To finance the acquisition and other corporate purposes, DBM Global secured a $220 million credit facility comprising an $110 million term loan and an $110 million revolving credit facility.BenzingaHC2 Stock Tumbles After Q1 Earnings Miss, Decline In Spectrum RevenueHC2 Holdings Inc reported first-quarter FY21 revenue of $171.8 million, a 7.9% decline year-over-year that missed the analyst consensus of $248.1 million. Non-GAAP EPS loss of ($0.35) also missed consensus expectations of ($0.20) loss, while adjusted EBITDA rose 134.5% year-over-year to $1 million. Following the sale of its Clean Energy segment and pending sale of its Insurance segment, HC2 is focusing on three strategic assets: Infrastructure, Life Sciences, and Spectrum, with DBM rebuilding its backlog and pursuing the acquisition of Banker Steel, R2 launching Glacial Rx commercially in the U.S., and Spectrum posting its second consecutive quarter of positive adjusted EBITDA.PR NewswireLa FDA concede la categoría de producto sanitario decisivo al sistema de MediBeacon de medición transdérmica de la VFGMediBeacon Inc. received Breakthrough Device designation from the FDA for its Transdermal Glomerular Filtration Rate (TGFR) system, designed to measure kidney function without blood or urine samples using an optical dermal sensor and proprietary fluorescent tracer MB-102. The device provides continuous, real-time GFR measurement at point of care, addressing kidney disease which affects over 850 million people worldwide. MediBeacon, majority-owned by HC2 Holdings through Pansend Life Sciences, plans to begin a pivotal multicenter clinical study in the United States and Europe.WsjHigh Yield Bond Ratings - Week Ended June 29, 2017Credit ratings for selected junk-rated companies were updated for the week ended June 29, 2017, including upgrades for Cablevision, Hecla Mining, and Amkor, a downgrade for Cenveo, and new ratings for Sirius XM and Belden. Affirmations were given to Bombardier, HC2 Holdings, AmeriGas, Jabil, and Sanmina.WsjHigh Yield Bond Ratings - Week Ended June 29, 2017Credit ratings for selected junk-rated companies were updated for the week ended June 29, 2017, including upgrades for Cablevision, Hecla Mining, and Amkor, a downgrade for Cenveo, and new ratings for Sirius XM and Belden. Affirmations were also issued for Bombardier, HC2 Holdings, AmeriGas, Jabil, and Sanmina.GlobeNewswireHC2 Holdings, Inc. Sets First Quarter 2017 Earnings Release Date and WebcastHC2 Holdings announced it will release its first-quarter 2017 financial results on May 10, 2017, after market close. The company will host an earnings conference call on the same day, with dial-in details provided. A replay will be available on the company's website.GlobeNewswireHC2 Holdings, Inc. Sets Fourth Quarter and Fiscal Year 2016 Earnings Release Date and WebcastHC2 Holdings announced it will release its fourth quarter and fiscal year 2016 financial results on March 8, 2017, after market close. The company will host an earnings conference call on the same day, with dial-in details provided. The call will be broadcast live and a replay will be available.